CYTOKINETICS INC Insider Trading for April 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CYTOKINETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CYTOKINETICS INC for April 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2021 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 6.30 | 5,000 | 31,500 | 49,065 | |
| Apr 30 2021 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 25.87 | 5,000 | 129,361 | 356,859 | 361.9 K to 356.9 K (-1.38 %) |
| Apr 30 2021 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 6.30 | 5,000 | 31,500 | 361,859 | 356.9 K to 361.9 K (+1.40 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 10.68 | 5,000 | 53,400 | 15,000 | |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 10.55 | 4,739 | 49,996 | 0 | |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 28.00 | 5,000 | 140,000 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 10.68 | 5,000 | 53,400 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 27.50 | 4,739 | 130,323 | 920 | 5.7 K to 920 (-83.74 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 10.55 | 4,739 | 49,996 | 5,659 | 920 to 5.7 K (+515.11 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 9.45 | 5,000 | 47,250 | 5,000 | |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 27.00 | 5,000 | 135,000 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 9.45 | 5,000 | 47,250 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 9.45 | 5,000 | 47,250 | 5,000 | |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 27.00 | 5,000 | 135,000 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 9.45 | 5,000 | 47,250 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 23 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 9.45 | 5,000 | 47,250 | 10,000 | |
| Apr 23 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 26.50 | 5,000 | 132,500 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 23 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 9.45 | 5,000 | 47,250 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 15 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 9.45 | 5,000 | 47,250 | 15,000 | |
| Apr 15 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 8.75 | 5,714 | 49,998 | 0 | |
| Apr 15 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 25.00 | 5,714 | 142,850 | 920 | 6.6 K to 920 (-86.13 %) |
| Apr 15 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 8.75 | 5,714 | 49,998 | 6,634 | 920 to 6.6 K (+621.09 %) |
| Apr 15 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 25.50 | 5,000 | 127,500 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 15 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 9.45 | 5,000 | 47,250 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Option Exercise | M | 6.30 | 5,000 | 31,500 | 54,065 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 23.56 | 5,000 | 117,813 | 356,859 | 361.9 K to 356.9 K (-1.38 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Buy | M | 6.30 | 5,000 | 31,500 | 361,859 | 356.9 K to 361.9 K (+1.40 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 10.00 | 4,375 | 43,750 | 0 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 7.61 | 5,000 | 38,050 | 0 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 7.61 | 5,000 | 38,050 | 5,000 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 7.61 | 5,000 | 38,050 | 10,000 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 7.61 | 5,000 | 38,050 | 15,000 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 6.82 | 3,207 | 21,872 | 0 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 24.50 | 4,375 | 107,188 | 920 | 5.3 K to 920 (-82.63 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 10.00 | 4,375 | 43,750 | 5,295 | 920 to 5.3 K (+475.54 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 23.79 | 5,000 | 118,950 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 7.61 | 5,000 | 38,050 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 23.79 | 5,000 | 118,943 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 7.61 | 5,000 | 38,050 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 23.80 | 5,000 | 118,995 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 7.61 | 5,000 | 38,050 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 23.79 | 5,000 | 118,948 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 7.61 | 5,000 | 38,050 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 24.00 | 3,207 | 76,968 | 920 | 4.1 K to 920 (-77.71 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 6.82 | 3,207 | 21,872 | 4,127 | 920 to 4.1 K (+348.59 %) |
| Apr 08 2021 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | EVP Research & Deve ... | Sell | S | 23.39 | 2,000 | 46,772 | 162,348 | 164.3 K to 162.3 K (-1.22 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | M | 8.64 | 1,100 | 9,504 | 0 | |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | M | 8.64 | 1,100 | 9,504 | 1,100 | |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Option Exercise | M | 8.64 | 1,133 | 9,789 | 2,200 | |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Sell | S | 23.31 | 1,100 | 25,641 | 7,410 | 8.5 K to 7.4 K (-12.93 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Buy | M | 8.64 | 1,100 | 9,504 | 8,510 | 7.4 K to 8.5 K (+14.84 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Sell | S | 23.31 | 1,100 | 25,641 | 7,410 | 8.5 K to 7.4 K (-12.93 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Buy | M | 8.64 | 1,100 | 9,504 | 8,510 | 7.4 K to 8.5 K (+14.84 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Sell | S | 24.00 | 1,133 | 27,192 | 7,410 | 8.5 K to 7.4 K (-13.26 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | HENDERSON JOHN T | Director | Buy | M | 8.64 | 1,133 | 9,789 | 8,543 | 7.4 K to 8.5 K (+15.29 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | Wysenski Nancy | Director | Grant | A | 24.44 | 204 | 4,986 | 459 | 255 to 459 (+80.00 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Grant | A | 24.44 | 409 | 9,996 | 920 | 511 to 920 (+80.04 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Grant | A | 24.44 | 409 | 9,996 | 920 | 511 to 920 (+80.04 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | Kaye Edward M. MD | Director | Grant | A | 24.44 | 409 | 9,996 | 920 | 511 to 920 (+80.04 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Grant | A | 24.44 | 767 | 18,745 | 22,529 | 21.8 K to 22.5 K (+3.52 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | Califf Robert | Director | Grant | A | 24.44 | 204 | 4,986 | 459 | 255 to 459 (+80.00 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | Callos Andrew | EVP, Chief Commerci ... | Option Exercise | A | 23.26 | 150,000 | 3,489,000 | 150,000 |